For bladder cancer, chemotherapy is either intravesical (put directly into the bladder with a catheter) or systemic (injected into a vein or given by pill to affect the whole body). Intravesical ...

Combination therapy with enfortumab vedotin (Padcev) and pembrolizumab (Keytruda) was associated with durable responses and ...

The FDA is currently evaluating the application of intravesical mitomycin for low-grade intermediate-risk non–muscle-invasive bladder cancer.

This study included a review of consecutive patients diagnosed with NMIBC between January 2005 and May 2023 to identify ...

Patients with muscle-invasive bladder cancer who underwent whole pelvis radiation showed improved cancer-specific survival and overall survival.

plus 'intravesical therapy': chemotherapy drugs or TB vaccine BCG applied via catheter. For invasive cancer: radiotherapy or surgery to remove all orpart of bladder. Advanced: intensive chemotherapy.

Patients were further queried to identify those who received adequate BCG induction (defined as ≥ 5 weekly instillations). They then summarized the distribution of this group and the treatments ...

The TROP2-directed antibody-drug conjugate failed to top chemotherapy at extending the lives of bladder cancer patients who had tried a PD-1/L1 therapy and chemo. Detailed data of that flop have ...

Johnson & Johnson has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization for BALVERSA®▼ (erdafitinib) as a monotherapy for the treatment ...

Chemotherapy for breast cancer doesn’t always have to be through an IV. Some drugs are available in pill form. Other oral medications that are part of breast cancer treatment include antihormone ...